Dual Kinase Inhibition of EGFR/HER2: Design, Synthesis and Molecular Docking of Thiazolylpyrazolyl‐Based Aminoquinoline Derivatives as Anticancer Agents**
- 25 October 2021
- journal article
- research article
- Published by Wiley in ChemistrySelect
- Vol. 6 (40) , 11012-11021
Abstract
Two new series of aminoquinoline based derivatives (thiazolyl pyrazolines and pyrazolyl thiazolidinones) were designed and synthesized. The in vitro antiporliferative activity of the target compounds was assessed against two different cancer types; (MCF‐7) breast cancer cell line and (HCT116) colorectal carcinoma cell line, using MTT assay technique. The 4‐methyl thiazolyl pyrazoline derivative 4 b showed potent anticancer activity on HCT116 with IC 50 value of 3.07 μM. The promising derivative exhibited dual kinase EGFR/HER2 inhibitory activity with IC 50 values of 0.06/0.08 μM versus 0.04/0.05 μM for erlotinib and lapatinib, respectively, as detected by EGFR and HER2 kinase assays. Moreover, the flow cytometry analysis of HCT116 cells treated with 4 b revealed that the derivative was capable of arresting the cell cycle at G1 phase and inducing late cellular apoptosis. Molecular docking of 4 b showed that the synthesized compound exhibited promising binding energy scores of −15.0774 and −16.9040 kcal/mol into EGFR and HER2 active sites, respectively. Finally, the pharmacokinetics and physicochemical parameters of 4 b showed its promising drug‐like properties.Keywords
This publication has 35 references indexed in Scilit:
- The Effect of Vorinostat on the Development of Resistance to Doxorubicin in NeuroblastomaPLOS ONE, 2012
- Design, synthesis and biological evaluation of pyrazolyl-thiazolinone derivatives as potential EGFR and HER-2 kinase inhibitorsBioorganic & Medicinal Chemistry, 2012
- Structural Analysis of the Mechanism of Inhibition and Allosteric Activation of the Kinase Domain of HER2 ProteinJournal of Biological Chemistry, 2011
- Cell Signaling by Receptor Tyrosine KinasesCell, 2010
- Design, synthesis and biological evaluation of thiazolidinone derivatives as potential EGFR and HER-2 kinase inhibitorsBioorganic & Medicinal Chemistry, 2010
- Induction of BIM Is Essential for Apoptosis Triggered by EGFR Kinase Inhibitors in Mutant EGFR-Dependent Lung AdenocarcinomasPLOS Medicine, 2007
- A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)Cancer Research, 2004
- Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine KinaseCancer Research, 2004
- The Hallmarks of CancerCell, 2000
- The type 1 (EGFR-related) family of growth factor receptors and their ligandsProgress in Growth Factor Research, 1992